Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.520
-0.060-1.08%
Volume:21.42M
Turnover:118.79M
Market Cap:103.13B
PE:36.48
High:5.645
Open:5.600
Low:5.485
Close:5.580
52wk High:9.017
52wk Low:4.190
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.52
T/O Rate:0.11%
Dividend:0.12
Dividend Rate:2.21%
EPS(LYR):0.151
ROE:14.07%
ROA:7.51%
PB:2.72
PE(LYR):36.48
PS:2.62

Loading ...

Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.67 From HK$8.26, Keeps at Buy

MT Newswires Live
·
Yesterday

Sino Biopharmaceutical (SEHK:1177) Could Be 66% Below Fair Value As Earnings Lift Interest

Simply Wall St.
·
Aug 22

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

SBP Group's Novel Weight Management Therapy Gains Regulatory Nod for Clinical Trials

Stock News
·
Aug 21

Sino Biopharm Says NMPA Clears Tqf6422 Obesity Drug Candidate for Clinical Trial

Reuters
·
Aug 21

Sino Biopharmaceutical - Application for Clinical Trial on Tqf6422 Injection "Actrii a/B Monoclonal Antibody" Approved by Nmpa

THOMSON REUTERS
·
Aug 21

Movement Alert|SBP GROUP Rises 3.15% in Regular Trading, Continued Post-Earnings Momentum Supported by Analyst Upgrades

Market Focus
·
Aug 21

Sino Biopharmaceutical (SEHK:1177) Stock Faces Margin Strain Despite Profit Recovery

Simply Wall St.
·
Aug 21

China's 3SBio H1 Net Profit Falls on Higher Expenses

Reuters
·
Aug 20

Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion

Reuters
·
Aug 20

Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again

Stock News
·
Aug 20

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 20

Citi Lifts SBP GROUP Price Target to HK$10.8, Citing Strong H1 Beat

Stock News
·
Aug 20

Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts

Reuters
·
Aug 20

Movement Alert|SBP GROUP Rises 10.33% in Regular Trading, H1 Earnings Beat Expectations with Revenue Hitting Record High

Market Focus
·
Aug 20

Hong Kong Stock Market Update: SBP GROUP Jumps Over 6% After Results, H1 Revenue Hits Record 19.44 Billion Yuan, Gaining Endorsements From Top Global Pharmaceutical Firms

Stock News
·
Aug 20

China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up

Reuters
·
Aug 20

Iceland's Alvotech H1 Revenue Falls 31% on Manufacturing Program

Reuters
·
Aug 20

Hong Kong's Sisram Medical H1 Profit Falls on China Injectables Investments

Reuters
·
Aug 19

Sino Biopharmaceutical - Launches New Global Brand Sbp Group

THOMSON REUTERS
·
Aug 19